StreetInsider.com News Articles

Spectral AI’s DeepView™ System Showcased at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly

Tue, 13 Oct 2026 08:30:00 -0400

DALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today highlighted its participation at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly, held October 5-8 in Chicago, IL.

The Company showcased its FDA-cleared DeepView™ System for Burn Indication at this year’s Assembly. Widely recognized as the world’s largest emergency medicine conference, the event drew an estimated 7,000 attendees.

“Having the DeepView System on display

Spectral AI’s DeepView™ System Showcased at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly

Tue, 13 Oct 2026 08:30:00 -0400

“Having the DeepView System on display

Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ System

Tue, 06 Oct 2026 08:30:00 -0400

DALLAS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the submission of a New Technology Add-On Payment (NTAP) application to the Centers for Medicare & Medicaid Services (CMS) for its DeepView™ System utilizing the alternative pathway.

The NTAP program is designed to provide an additional hospital inpatient payment for eligible procedures involving new technologies or medical services that meet CMS requirements, helping to address the additional

Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ System

Tue, 06 Oct 2026 08:30:00 -0400

Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and Feet

Thu, 01 Oct 2026 08:30:00 -0400

DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the completion of the first Site Initiation Visit (“SIV”) associated with the commencement of a clinical study designed to support a label expansion of the Company’s FDA-cleared DeepView System™ for Burn Indication to include burns involving the head, hands and feet.

The SIV was conducted at Pinderfields Hospital, Wakefield, UK under the leadership of Principal Investigator Dr.

Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and Feet

Thu, 01 Oct 2026 08:30:00 -0400

The SIV was conducted at Pinderfields Hospital, Wakefield, UK under the leadership of Principal Investigator Dr.

Form 4 Spectral AI, Inc. For: Sep 28 Filed by: DiMaio John Michael

Tue, 29 Sep 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260929/27122284.html

Form 4 Spectral AI, Inc. For: Sep 23 Filed by: DiMaio John Michael

Fri, 25 Sep 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260925/27107311.html

Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds

Thu, 24 Sep 2026 16:15:00 -0400

DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a scheduled presentation at the upcoming ACS Clinical Congress 2026, being held September 26-29, 2026 in Washington, DC.

Entitled “Artificial Intelligence Training & Validation of Multi-Spectral Imaging Device for Evaluation of Burn Wounds,” the presentation will be led by James H. Holmes IV, MD, FACS, FABA, Director of the Burn Center at Atrium Health Wake Forest Baptist

Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds

Thu, 24 Sep 2026 16:15:00 -0400

Form 4 Spectral AI, Inc. For: Sep 18 Filed by: DiMaio John Michael

Mon, 21 Sep 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260921/27085845.html

Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference

Wed, 16 Sep 2026 16:15:00 -0400

Announces Upcoming Burn Conference Schedule

DALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the Southern Regional Burn Conference (SRBC), held September 10-12, 2026 in Williamsburg, Virginia.

The Company’s DeepView^® System for Burn Indication was on display for attending burn care clinicians and was the subject of KOL presentations that support the use of AI and multispectral imaging in the assessment of

Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference

Wed, 16 Sep 2026 16:15:00 -0400

Announces Upcoming Burn Conference Schedule

Form 8-K Spectral AI, Inc. For: Sep 14

Tue, 15 Sep 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260915/27064804.html

Form 4 Spectral AI, Inc. For: Sep 10 Filed by: DiMaio John Michael

Mon, 14 Sep 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260914/27058655.html

Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference

Tue, 01 Sep 2026 08:30:00 -0400

Company to Highlight Growth Strategy and Readiness for 2026 Commercial Launch of FDA-Cleared DeepView® System for Burn Indication

DALLAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Vincent Capone, Chief Executive Officer, and David McGuire, Chief Financial Officer, are scheduled to present at the H.C. Wainwright 28^th Annual Global Investment Conference, taking place September 14−16, 2026 in New York City.

“The receipt of FDA De Novo Clearance

Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference

Tue, 01 Sep 2026 08:30:00 -0400

Company to Highlight Growth Strategy and Readiness for 2026 Commercial Launch of FDA-Cleared DeepView® System for Burn Indication

“The receipt of FDA De Novo Clearance

Form 4 Spectral AI, Inc. For: Aug 13 Filed by: DiMaio John Michael

Mon, 17 Aug 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260817/26938218.html

Form 4 Spectral AI, Inc. For: Aug 13 Filed by: DiMaio John Michael

Mon, 17 Aug 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260817/26938218.html

Form SCHEDULE 13G Spectral AI, Inc. Filed by: LMR Partners LLP

Fri, 14 Aug 2026 09:48:00 -0400

si-local-file:///var/storage/secattach/20260814/26925949.html

Form SCHEDULE 13G Spectral AI, Inc. Filed by: LMR Partners LLP

Fri, 14 Aug 2026 09:48:00 -0400

si-local-file:///var/storage/secattach/20260814/26925949.html

Form 8-K Spectral AI, Inc. For: Aug 11

Wed, 12 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26912630.html

Form 8-K Spectral AI, Inc. For: Aug 11

Wed, 12 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26912630.html

Spectral AI, Inc. (MDAI) Tops Q2 EPS by 2c

Tue, 11 Aug 2026 16:30:08 -0400

Spectral AI, Inc. (NASDAQ: MDAI) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Spectral AI, Inc. (MDAI) click here.

Spectral AI Announces 2026 Second Quarter Financial Results

Tue, 11 Aug 2026 16:05:00 -0400

Company Continues to Advance Towards First Commercial Sales of the DeepView® System for Burn Indication

Strong Cash Position of $14.0 Million at June 30, 2026

DALLAS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the second quarter ended June 30, 2026 (“Q2 2026”).

“Spectral AI has entered the second half of 2026 with tremendous momentum and a clear sense of purpose,” said